These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28556412)

  • 1. Patient-reported outcomes in Huntington's disease: Quality of life in neurological disorders (Neuro-QoL) and Huntington's disease health-related quality of life (HDQLIFE) physical function measures.
    Carlozzi NE; Ready RE; Frank S; Cella D; Hahn EA; Goodnight SM; Schilling SG; Boileau NR; Dayalu P
    Mov Disord; 2017 Jul; 32(7):1096-1102. PubMed ID: 28556412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDQLIFE and neuro-QoL physical function measures: Responsiveness in persons with huntington's disease.
    Carlozzi NE; Boileau NR; Chou KL; Ready RE; Cella D; McCormack MK; Miner JA; Dayalu P
    Mov Disord; 2020 Feb; 35(2):326-336. PubMed ID: 31724237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability and Validity of the HD-PRO-TriadTM, a Health-Related Quality of Life Measure Designed to Assess the Symptom Triad of Huntington's Disease.
    Boileau NR; Stout JC; Paulsen JS; Cella D; McCormack MK; Nance MA; Frank S; Lai JS; Carlozzi NE
    J Huntingtons Dis; 2017; 6(3):201-215. PubMed ID: 28968239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding speech and swallowing difficulties in individuals with Huntington disease: Validation of the HDQLIFE Speech Difficulties and Swallowing Difficulties Item Banks.
    Carlozzi NE; Boileau NR; Roberts A; Dayalu P; Hanifan DL; Miner JA; Claassen D; Provost EM
    Qual Life Res; 2021 Jan; 30(1):251-265. PubMed ID: 32839864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meaningful and Measurable Health Domains in Huntington's Disease: Large-Scale Validation of the Huntington's Disease Health-Related Quality of Life Questionnaire Across Severity Stages.
    Ho AK; Horton MC; Landwehrmeyer GB; Burgunder JM; Tennant A;
    Value Health; 2019 Jun; 22(6):712-720. PubMed ID: 31198189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-reported outcome measures in Huntington disease: Quality of life in neurological disorders (Neuro-QoL) social functioning measures.
    Carlozzi NE; Hahn EA; Goodnight SM; Kratz AL; Paulsen JS; Stout JC; Frank S; Miner JA; Cella D; Gershon RC; Schilling SG; Ready RE
    Psychol Assess; 2018 Apr; 30(4):450-458. PubMed ID: 28557480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of Neuro-QoL and PROMIS Mental Health Patient Reported Outcome Measures in Persons with Huntington Disease.
    Carlozzi NE; Goodnight S; Kratz AL; Stout JC; McCormack MK; Paulsen JS; Boileau NR; Cella D; Ready RE
    J Huntingtons Dis; 2019; 8(4):467-482. PubMed ID: 31424415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responsiveness to Change Over Time: An Examination of the Neuro-QoL Social Function Measures in Persons with Huntington's Disease.
    Carlozzi NE; Boileau NR; Hahn EA; Barton SK; Cella D; McCormack MK; Ready RE
    J Huntingtons Dis; 2020; 9(1):83-97. PubMed ID: 31744014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating cognition in individuals with Huntington disease: Neuro-QoL cognitive functioning measures.
    Lai JS; Goodnight S; Downing NR; Ready RE; Paulsen JS; Kratz AL; Stout JC; McCormack MK; Cella D; Ross C; Russell J; Carlozzi NE
    Qual Life Res; 2018 Mar; 27(3):811-822. PubMed ID: 29222609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDQLIFE: development and assessment of health-related quality of life in Huntington disease (HD).
    Carlozzi NE; Schilling SG; Lai JS; Paulsen JS; Hahn EA; Perlmutter JS; Ross CA; Downing NR; Kratz AL; McCormack MK; Nance MA; Quaid KA; Stout JC; Gershon RC; Ready RE; Miner JA; Barton SK; Perlman SL; Rao SM; Frank S; Shoulson I; Marin H; Geschwind MD; Dayalu P; Goodnight SM; Cella D
    Qual Life Res; 2016 Oct; 25(10):2441-2455. PubMed ID: 27522213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of Life in Huntington's Disease: Critique and Recommendations for Measures Assessing Patient Health-Related Quality of Life and Caregiver Quality of Life.
    Mestre TA; Carlozzi NE; Ho AK; Burgunder JM; Walker F; Davis AM; Busse M; Quinn L; Rodrigues FB; Sampaio C; Goetz CG; Cubo E; Martinez-Martin P; Stebbins GT;
    Mov Disord; 2018 May; 33(5):742-749. PubMed ID: 29570848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development of a new computer adaptive test to evaluate chorea in Huntington disease: HDQLIFE Chorea.
    Carlozzi NE; Downing NR; Schilling SG; Lai JS; Goodnight SM; Miner JA; A Frank S
    Qual Life Res; 2016 Oct; 25(10):2429-2439. PubMed ID: 27141833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HDQLIFE: the development of two new computer adaptive tests for use in Huntington disease, Speech Difficulties, and Swallowing Difficulties.
    Carlozzi NE; Schilling SG; Lai JS; Perlmutter JS; Nance MA; Waljee JF; Miner JA; Barton SK; Goodnight SM; Dayalu P
    Qual Life Res; 2016 Oct; 25(10):2417-2427. PubMed ID: 27038054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How different aspects of motor dysfunction influence day-to-day function in huntington's disease.
    Carlozzi NE; Schilling SG; Boileau NR; Chou KL; Perlmutter JS; Frank S; McCormack MK; Stout JC; Paulsen JS; Lai JS; Dayalu P
    Mov Disord; 2019 Dec; 34(12):1910-1914. PubMed ID: 31609508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Huntington's Disease Dysphagia Scale.
    Heemskerk AW; Verbist BM; Marinus J; Heijnen B; Sjögren EV; Roos RA
    Mov Disord; 2014 Sep; 29(10):1312-6. PubMed ID: 24862624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships Among Apathy, Health-Related Quality of Life, and Function in Huntington's Disease.
    Fritz NE; Boileau NR; Stout JC; Ready R; Perlmutter JS; Paulsen JS; Quaid K; Barton S; McCormack MK; Perlman SL; Carlozzi NE;
    J Neuropsychiatry Clin Neurosci; 2018; 30(3):194-201. PubMed ID: 29558861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding patient-reported outcome measures in Huntington disease: at what point is cognitive impairment related to poor measurement reliability?
    Carlozzi NE; Schilling S; Kratz AL; Paulsen JS; Frank S; Stout JC
    Qual Life Res; 2018 Oct; 27(10):2541-2555. PubMed ID: 29909483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the first quality-of-life measurement for patients with Huntington's disease: the Huntington Quality of Life Instrument.
    Clay E; De Nicola A; Dorey J; Squitieri F; Aballéa S; Martino T; Tedroff J; Zielonka D; Auquier P; Verny C; Toumi M
    Int Clin Psychopharmacol; 2012 Jul; 27(4):208-14. PubMed ID: 22508443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuro-QoL health-related quality of life measurement system: Validation in Parkinson's disease.
    Nowinski CJ; Siderowf A; Simuni T; Wortman C; Moy C; Cella D
    Mov Disord; 2016 May; 31(5):725-33. PubMed ID: 26919664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health state utility values (QALY weights) for Huntington's disease: an analysis of data from the European Huntington's Disease Network (EHDN).
    Hawton A; Green C; Goodwin E; Harrower T
    Eur J Health Econ; 2019 Dec; 20(9):1335-1347. PubMed ID: 31410669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.